Spanish Researchers Show Photoswitchable Drug Candidates Restore Vision
Researchers in Spain have developed photoswitchable small-molecule compounds that can restore visual function in animal models of retinal degeneration. This noninvasive approach aims to bypass the need for gene therapy or implants by reactivating existing retinal circuitry.
Researchers led by the Institute for Bioengineering of Catalonia (IBEC) in Barcelona, Spain, have developed a new class of photoswitchable small-molecule compounds that restored vision-related behaviors in animal models of retinal degeneration, advancing a noninvasive approach to vision restoration that does not require gene therapy or implanted devices.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in